Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort von de Castro, Tiago, Welland, Sabrina, Jochheim, Leonie, Leyh, Cathrine, Shmanko, Kateryna, Finkelmeier, Fabian, Jeliazkova, Petia, Jefremow, Andre, Gonzalez-Carmona, Maria A, Kandulski, Arne, Roessler, Daniel, Ben Khaled, Najib, Enssle, Stefan, Venerito, Marino, Fründt, Thorben W, Schultheiß, Michael, Djanani, Angela, Pangerl, Maria, Maieron, Andreas, Wirth, Thomas C, Marquardt, Jens U, Greil, Richard, Fricke, Christina, Günther, Rainer, Schmiderer, Andreas, Bettinger, Dominik, Wege, Henning, Scheiner, Bernhard, Müller, Martina, Strassburg, Christian P, Siebler, Jürgen, Ehmer, Ursula, Waidmann, Oliver, Weinmann, Arndt, Pinter, Matthias, Lange, Christian M, Saborowski, Anna, Vogel, Arndt

Volltext